Equity · Basic Materials
GEVO
NASDAQGevo, Inc.
The line runs 1.59 USD on 17 September through 1.16 USD on 23 October, on a scale from 1.0 to 1.6. Days the market did not trade hold the previous close, flat.
- Market cap
- 286.8M USD
- Revenue, year to Dec 2025
- 160.6M USD
- EPS, diluted, year to Dec 2025
- −0.14 USD
- 52-week range
- 1.12 USD – 2.77 USD
- Avg volume
- 273.6K
as of Oct 23, 2026
Have GEVO insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, GEVO insiders reported 7 open-market sales and 2 purchases (SEC Form 4).
Form 4, 90 days to 1 Nov 2026, newest reported trade 3 Sep 2026
Buys 2Sells 7Net sold $380KOther filings 2
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Sep 2026 | Bloom Paul DCEO | Sell | 1,514 | 3K USD |
| 03 Sep 2026 | Bowron Kimberly TChief of Staff | Sell | 1,221 | 2K USD |
| 03 Sep 2026 | Gruber Patrick R.Director | Sell | 3,333 | 6K USD |
| 21 Aug 2026 | Barber James JDirector | Buy | 50,000 | 77K USD |
| 21 Aug 2026 | Kettner David MichaelChief Legal & Emrg Biz Officer | Buy | 12,500 | 19K USD |
| 06 Aug 2026 | Agiri Oluwagbemileke YusufCFO | Sell | 18,223 | 28K USD |
| 06 Aug 2026 | Bloom Paul DCEO | Sell | 31,096 | 48K USD |
| 06 Aug 2026 | Bowron Kimberly TChief of Staff | Sell | 10,257 | 16K USD |
| 06 Aug 2026 | Gruber Patrick R.Director | Sell | 247,642 | 374K USD |
| Bought | 2 open-market purchases | 62,500 | $96K | |
| Sold | 7 open-market sales | 313,286 | $476K |
2 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 20 Aug 2026 | Werpy Todd AllenDirector | Award | 62,583 | |
| 13 Aug 2026 | Bloom Paul DCEO | Option exercise | 50,000 | 59K USD |
Which funds hold GEVO?
6 of the 45 institutional funds we track reported a GEVO position for the quarter ended 30 Jun 2026 — a combined 3.5M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Trimmed | 1,211,562 | 1.8M USD | −41.3% |
| Millennium Management | New position | 447,528 | 671K USD | |
| Man Group | New position | 332,821 | 499K USD | |
| Two Sigma Investments | Trimmed | 286,638 | 430K USD | −27.0% |
| AQR Capital Management | Trimmed | 27,254 | 41K USD | −55.1% |
| Balyasny Asset Management | Trimmed | 17,581 | 26K USD | −92.2% |
| Marshall Wace | Exited | |||
| Point72 Asset Management | Exited | |||
| Renaissance Technologies | Exited |
Have members of Congress traded GEVO?
The most recent congressional trade disclosed in GEVO is a purchase by Sara Jacobs (house, CA), dated 12 Dec 2022.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 12 Dec 2022 | Sara Jacobshouse · Democrat–CA | Purchase | 1K USD–15K USD | 39 days |
| 08 Nov 2022 | Sara Jacobshouse · Democrat–CA | Sale | 1K USD–15K USD | 34 days |
| 18 Jul 2022 | Sara Jacobshouse · Democrat–CA | Sale | 1K USD–15K USD | 53 days |
What has been filed or recorded for GEVO?
The filings we hold for GEVO, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 09 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 96,841 shares | 131K USD notional · 0.039% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 35,375 shares | 46K USD notional · 0.014% of shares out |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 60 shares | 80 USD notional · <0.001% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 3,389,909 shares | 5.2M USD notional · 1.371% of shares out |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 3,440,464 shares | 5.4M USD notional · 1.392% of shares out |
| 18 Sep 2026 | Fails to deliver | Shares failed to deliver | 156,755 shares | 249K USD notional · 0.063% of shares out |
| 16 Sep 2026 | Fails to deliver | Shares failed to deliver | 48,656 shares | 76K USD notional · 0.020% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.75 USD | |
| 30 Jun 2026 | Financials | Total assets | 490.7M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 273.2M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.09 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.14 USD | |
| 31 Dec 2025 | Financials | Revenue | 160.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −33.8M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.14 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.03 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.01 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.09 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.34 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.09 USD |
GEVO: frequently asked questions
What did GEVO shares close at?
GEVO closed at 1.16 USD on 23 Oct 2026, up 2.65% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is GEVO’s market cap?
GEVO is worth 286.8M USD by market value as of 23 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is GEVO’s revenue?
GEVO reported revenue of 160.6M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have GEVO insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, GEVO insiders reported 7 open-market sales and 2 purchases (SEC Form 4). A further 2 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own GEVO?
6 of the 45 funds we track reported a GEVO position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Millennium Management and Man Group. See Funds
Have members of Congress traded GEVO?
Yes. 3 trades in GEVO appear in the congressional disclosures we hold; the latest is a purchase by Sara Jacobs (House, CA) dated 12 Dec 2022, filed 20 Jan 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did GEVO last report earnings?
GEVO last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.75 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Gevo